Morgan Stanley’s Biomerica BMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-169
| Closed | -$478 | – | 8229 |
|
|
2025
Q3 | $478 | Buy |
+169
| New | +$535 | ﹤0.01% | 7502 |
|
|
2024
Q4 | – | Sell |
-39
| Closed | -$103 | – | 7983 |
|
|
2024
Q3 | $103 | Sell |
39
-32
| -45% | -$92 | ﹤0.01% | 7437 |
|
|
2024
Q2 | $248 | Sell |
71
-2
| -3% | -$10 | ﹤0.01% | 7285 |
|
|
2024
Q1 | $483 | Sell |
73
-39
| -35% | -$317 | ﹤0.01% | 7242 |
|
|
2023
Q4 | $1.12K | Hold |
112
| – | – | ﹤0.01% | 7123 |
|
|
2023
Q3 | $770 | Hold |
112
| – | – | ﹤0.01% | 7264 |
|
|
2023
Q2 | $1.22K | Buy |
112
+2
| +2% | +$24 | ﹤0.01% | 7271 |
|
|
2023
Q1 | $1.65K | Hold |
110
| – | – | ﹤0.01% | 7273 |
|
|
2022
Q4 | $2.96K | Hold |
110
| – | – | ﹤0.01% | 7272 |
|
|
2022
Q3 | $3K | Sell |
110
-94
| -46% | -$2.44K | ﹤0.01% | 7366 |
|
|
2022
Q2 | $5K | Sell |
204
-111
| -35% | -$3.17K | ﹤0.01% | 7390 |
|
|
2022
Q1 | $12K | Buy |
315
+49
| +18% | +$1.63K | ﹤0.01% | 7341 |
|
|
2021
Q4 | $8K | Buy |
266
+60
| +29% | +$2.31K | ﹤0.01% | 7524 |
|
|
2021
Q3 | $7K | Sell |
206
-624
| -75% | -$20.5K | ﹤0.01% | 7414 |
|
|
2021
Q2 | $26K | Buy |
830
+70
| +9% | +$2.37K | ﹤0.01% | 6908 |
|
|
2021
Q1 | $33K | Sell |
760
-19
| -2% | -$974 | ﹤0.01% | 6540 |
|
|
2020
Q4 | $31K | Buy |
779
+19
| +3% | +$952 | ﹤0.01% | 6302 |
|
|
2020
Q3 | $42K | Hold |
760
| – | – | ﹤0.01% | 5780 |
|
|
2020
Q2 | $44K | Sell |
760
-1,244
| -62% | -$69.7K | ﹤0.01% | 5719 |
|
|
2020
Q1 | $115K | Buy |
+2,004
| New | +$61.1K | ﹤0.01% | 5130 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6593 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6596 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6612 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6568 |
|
|
2017
Q3 | – | Sell |
-492
| Closed | -$10K | – | 6530 |
|
|
2017
Q2 | $10K | Hold |
492
| – | – | ﹤0.01% | 6238 |
|
|
2017
Q1 | $9K | Buy |
492
+13
| +3% | +$246 | ﹤0.01% | 6247 |
|
|
2016
Q4 | $9K | Hold |
479
| – | – | ﹤0.01% | 6175 |
|
|
2016
Q3 | $10K | Buy |
+479
| New | +$10.6K | ﹤0.01% | 6109 |
|
Other funds holding BMRA
DS
NA
HCM
HI
Morgan Stanley's BMRA Position: Q4 2025 in Review
Morgan Stanley sold out of Biomerica (BMRA) in Q4 2025, closing a stake of 169 shares — an estimated $478 sold.
Morgan Stanley first reported a position in BMRA in Q3 2016 and held it in 24 quarters. The position peaked at $115K in Q1 2020. 13 funds tracked by Wall St. Rank hold BMRA as of Q4 2025.
- Morgan Stanley reported no remaining Biomerica position as of Q4 2025 after selling out during the quarter.
- Morgan Stanley sold 169 Biomerica shares in Q4 2025, an estimated $478.
- Morgan Stanley first reported a position in Biomerica in Q3 2016 and held it in 24 quarters.
- Morgan Stanley's Biomerica position peaked at $115K in Q1 2020.
- 13 funds tracked by Wall St. Rank held Biomerica as of Q4 2025.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.